Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srilatha Swami

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Endocrinology|June 14, 2011
Vitamin D metabolism and action in the prostate: implications for health and diseaseSrilatha Swami, Aruna V Krishnan, David Feldman
The Journal of Steroid Biochemistry and Molecular Biology|February 17, 2010
Vitamin D and breast cancer: inhibition of estrogen synthesis and signalingAruna V Krishnan, Srilatha Swami, David Feldman
Steroids|July 18, 2012
The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancerAruna V Krishnan, Srilatha Swami, David Feldman
The Journal of Steroid Biochemistry and Molecular Biology|September 4, 2012
Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and preventionAruna V Krishnan, Srilatha Swami, David Feldman
Biomaterials|February 20, 2018
Pluripotent stem cells as a source of osteoblasts for bone tissue regenerationHui Zhu, Takaharu Kimura, Srilatha Swami, et al.
Molecular and Cellular Endocrinology|June 16, 2005
Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activitySrilatha Swami, Aruna V Krishnan, Donna M Peehl, et al.
The Prostate|March 30, 2012
Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancerJennifer Y Wang, Srilatha Swami, Aruna V Krishnan, et al.
Molecular Cancer Therapeutics|July 5, 2006
Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cellsRumi S Bhattacharyya, Aruna V Krishnan, Srilatha Swami, et al.
Endocrine-Related Cancer|June 8, 2013
Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elementsSrilatha Swami, Aruna V Krishnan, Lihong Peng, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 4, 2019
Direct Reprogramming of Mouse Fibroblasts into Functional OsteoblastsHui Zhu, Srilatha Swami, Pinglin Yang, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Endocrinology|June 14, 2011
Vitamin D metabolism and action in the prostate: implications for health and diseaseSrilatha Swami, Aruna V Krishnan, David Feldman
The Journal of Steroid Biochemistry and Molecular Biology|February 17, 2010
Vitamin D and breast cancer: inhibition of estrogen synthesis and signalingAruna V Krishnan, Srilatha Swami, David Feldman
Steroids|July 18, 2012
The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancerAruna V Krishnan, Srilatha Swami, David Feldman
The Journal of Steroid Biochemistry and Molecular Biology|September 4, 2012
Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and preventionAruna V Krishnan, Srilatha Swami, David Feldman
Biomaterials|February 20, 2018
Pluripotent stem cells as a source of osteoblasts for bone tissue regenerationHui Zhu, Takaharu Kimura, Srilatha Swami, et al.
Molecular and Cellular Endocrinology|June 16, 2005
Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activitySrilatha Swami, Aruna V Krishnan, Donna M Peehl, et al.
The Prostate|March 30, 2012
Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancerJennifer Y Wang, Srilatha Swami, Aruna V Krishnan, et al.
Molecular Cancer Therapeutics|July 5, 2006
Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cellsRumi S Bhattacharyya, Aruna V Krishnan, Srilatha Swami, et al.
Endocrine-Related Cancer|June 8, 2013
Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elementsSrilatha Swami, Aruna V Krishnan, Lihong Peng, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 4, 2019
Direct Reprogramming of Mouse Fibroblasts into Functional OsteoblastsHui Zhu, Srilatha Swami, Pinglin Yang, et al.
Pageof 4